These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15980888)

  • 1. Cell death pathways in retroviral infection.
    Piacentini M; Kroemer G
    Cell Death Differ; 2005 Aug; 12 Suppl 1():835-6. PubMed ID: 15980888
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropathology of HIV-1 and HTLV-1 infection.
    Scaravilli F
    Baillieres Clin Neurol; 1992 Apr; 1(1):211-38. PubMed ID: 1344650
    [No Abstract]   [Full Text] [Related]  

  • 3. Retroviruses and inflammatory myopathies in humans and primates.
    Dalakas MC
    Baillieres Clin Neurol; 1993 Nov; 2(3):659-91. PubMed ID: 8156147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An important task even in the HAART era (High Activity Anti-Retroviral Therapy). Infection management in HIV-patients].
    Internist (Berl); 1999 Mar; 40(3 Suppl Infektions):1-4. PubMed ID: 10202682
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic aspects of retroviral disease.
    Peto T
    Baillieres Clin Neurol; 1992 Apr; 1(1):239-57. PubMed ID: 1344652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrovirus infection and neurological disorders].
    Izumo S; Kubota R; Xing HQ
    No To Shinkei; 2006 Jul; 58(7):595-604. PubMed ID: 16910468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiretroviral treatment: are we entering or exiting the tunnel?].
    Gatell JM; Miró JM
    Med Clin (Barc); 1995 Apr; 104(16):622-5. PubMed ID: 7752715
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuronal damage - recent issues and implications for therapy.
    Everall IP
    J Neurovirol; 2000 May; 6 Suppl 1():S103-5. PubMed ID: 10871773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of autoantibodies and factor VIII inhibitor in an HIV-infected haemophiliac following treatment with combination anti-retroviral therapy.
    Evans GD; Mendelson GM; Lever AM; Baglin TP
    Br J Haematol; 1998 Sep; 102(5):1382-3. PubMed ID: 9753077
    [No Abstract]   [Full Text] [Related]  

  • 10. [5th Conference on Opportunistic Retrovirus Infections in HIV: contribution of anti-retroviral combinations].
    Granier F; Valantin MA
    Presse Med; 1998 Apr; 27(13):622-3. PubMed ID: 9767939
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological basis for immunopharmacology in the control of early infection with human retroviruses.
    D'Onofrio C; Guerriero M; Bonmassar E
    Pharmacol Res; 1992 Sep; 26 Suppl 2():56-7. PubMed ID: 1329064
    [No Abstract]   [Full Text] [Related]  

  • 12. Deletion and depletion: the involvement of viruses and environmental factors in T-lymphocyte apoptosis.
    McCabe MJ; Orrenius S
    Lab Invest; 1992 Apr; 66(4):403-6. PubMed ID: 1316526
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies in initiating anti-retroviral therapy and in the use of combination therapies.
    Volberding PA
    Adv Exp Med Biol; 1996; 394():333-43. PubMed ID: 8815699
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolving paradigms in the pathogenesis of HIV-1-associated dementia.
    Fischer-Smith T; Rappaport J
    Expert Rev Mol Med; 2005 Dec; 7(27):1-26. PubMed ID: 16321172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral arthritis.
    Calabrese LH; Naides SJ
    Infect Dis Clin North Am; 2005 Dec; 19(4):963-80, x. PubMed ID: 16297742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does HIV-1/AIDS-associated frontotemporal neuropathology following perinatal infection influence the development of moral behaviour?
    Gericke GS
    Med Hypotheses; 2008; 70(6):1139-46. PubMed ID: 18255237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CCR5 antagonists: a new class of antiretrovirals].
    Peytavin G; Calvez V; Katlama C
    Therapie; 2009; 64(1):9-16. PubMed ID: 19463248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New initiatives in combination antiretroviral chemotherapy.
    Rooney JF; Warwick JC; Elkins MM; St Clair MH; Barry DW
    Adv Exp Med Biol; 1996; 394():373-82. PubMed ID: 8815702
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease.
    Price RW
    Cold Spring Harb Symp Quant Biol; 1996; 61():759-70. PubMed ID: 9246501
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell activation: a cellular target for antiretroviral therapy.
    Fidler S; Weber J
    Eur J Clin Invest; 2000 Feb; 30(2):95-8. PubMed ID: 10651832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.